1-20 of 247
Andrew D. Zelenetz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease (MRD)-Adapted Duration of Front-Line Venetoclax and Obinutuzumab Treatment for Fit Patients with Chronic Lymphocytic Leukemia (CLL)

Lindsey Roeker, Anthony R. Mato, Andrew D. Zelenetz, Jae H. Park, Mark Blaine Geyer, Andriy Derkach, David Nemirovsky, Prioty Islam, Lorenzo Falchi, Maria Lia Palomba, Anita Kumar, Gilles Salles, Jennifer Kimberly Lue, Aaron D. Goldberg, Deborah M. Stephens, Victoria Duffy, Gail Panton, Dianna Tyznar, Colleen Dorsey, Dhara Soni, Claire Hutzler, Lauren Nogan, Alexandra Allen, Tenzin Nyima, Thu Quynh Nguyen, Monica Shah, Tamotha R Cook, Jennifer Abillar-Wright, Jamila Brutus, Carissa Laudati, Bejal Kikani, Catherine C Coombs, Michael R. Silvestrone, Christopher E. Jensen, Bita Fakhri, Meghan C. Thompson
Journal: Blood
Blood (2024) 144 (Supplement 1): 1010.
https://doi.org/10.1182/blood-2024-203807
Published: 2024
Journal Articles

Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis

Zachary D. Epstein-Peterson, Anath C. Lionel, Ashlee Joseph, Esther Drill, Suheil Albert Atallah-Yunes, Taylor R. Brooks, Elise A. Chong, Emeline R. Chong, Jamie Dela Cruz, Matthew J. Frank, Andrew Ip, Madiha Iqbal, Caron A. Jacobson, Manali K. Kamdar, Reem Karmali, Kami J. Maddocks, Matthew Matasar, Reid W. Merryman, Javier Munoz, Peter A. Riedell, Christine E. Ryan, Gilles Salles, Craig S. Sauter, Yazeed Sawalha, Roni Shouval, Navika Shukla, Alexander V. Stanisic, Dylan Therwhanger, Herman Van Besien, Yucai Wang, Samuel Yamshon, Andrew D. Zelenetz, Maria Lia Palomba, Preetesh Jain, Anita Kumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 238.
https://doi.org/10.1182/blood-2024-192995
Published: 2024
Journal Articles

Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin

Alison Moskowitz, Gunjan L. Shah, Nivetha Ganesan, Tiffany Chang, Esther Drill, Theresa Davey, Helen Hancock, Brittney Munayirji, Monifa Douglas, Alayna M. Santarosa, Ellie Casper, Natasha Galasso, Sarima Subzwari, Marwah Jihad, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Raphael Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Joachim Yahalom, Ahmet Dogan, Heiko Schoder, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 569.
https://doi.org/10.1182/blood-2024-202537
Published: 2024
Journal Articles

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Alexandra Dreyfuss, Nivetha Ganesan, Alvaro J Alencar, Alexander P. Boardman, Philip Caron, Tiffany Chang, Theresa Davey, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Beatrice Fregonese, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Brandon S. Imber, Andrew M. Intlekofer, Derek Isrow, Erel Joffe, William T. Johnson, Anita Kumar, Michael Lariviere, Jennifer Kimberly Lue, Efrat Luttwak, Michael McNicholas, Zachary Moore, Brittney Munayirji, Ariela Noy, Colette Owens, Maria Lia Palomba, Jaldhi Patel, John P Plastaras, Alayna M. Santarosa, Heiko Schoder, Gunjan L. Shah, Raphael E. Steiner, Robert Stuver, Jakub Svoboda, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Joachim Yahalom, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4434.
https://doi.org/10.1182/blood-2024-210689
Published: 2024
Journal Articles

Improved Outcomes for Primary Refractory Classical Hodgkin Lymphoma: A Retrospective Analysis

Alayna M. Santarosa, Nivetha Ganesan, Tiffany Chang, Kelly Hannigan, Ellie Casper, Gunjan L. Shah, Alexander P. Boardman, Philip Caron, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Ariel Krivisky, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Heiko Schoder, Raphael E. Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2024-203857
Published: 2024
Journal Articles

Rituximab +/- Ibrutinib As First Line Therapy for Marginal Zone Lymphoma

Ariela Noy, Win Su Thet, Shreya Vemuri, Venkatraman Seshan, Connie Lee Batlevi, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Thomas M. Habermann, Paul A. Hamlin, Erel Joffe, Jennifer Kimberly Lue, Matthew Matasar, Maria Lia Palomba, Andrew D. Zelenetz, Gilles Salles
Journal: Blood
Blood (2024) 144 (Supplement 1): 6352.
https://doi.org/10.1182/blood-2024-211730
Published: 2024
Journal Articles

Final Analysis of the Safety and Efficacy of Venetoclax in Combination with Pola-R-CHP for Untreated High-Risk BCL-2-Positive B-Cell Lymphoma Including Double/Triple Hit Lymphoma

Catherine S. Diefenbach, Andrew D. Zelenetz, Charles Herbaux, Monica Tani, Roch Houot, Mariana Bastos-Oreiro, Hervé Tilly, Thomas Gastinne, Catherine Thieblemont, Wilfred Leung, Katerina Hatzi, Murali Kesavan, Simona Barlera, Michelle Boyer, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 577.
https://doi.org/10.1182/blood-2024-198624
Published: 2024
Journal Articles

Two Decade Single Institution Experience Highlights Rare Survivors with Relapsed or Refractory Burkitt Lymphoma

Rabeya Molla, Ellin Berman, Philip Caron, Gerard Donnelly, Lorenzo Falchi, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Joseph G Jurcic, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Colette Owens, Parastoo B Dahi, Maria Lia Palomba, Carol S. Portlock, Gilles Salles, Craig S Sauter, Santosha A. Vardhana, Gunjan L. Shah, David J. Straus, Anas Younes, Anas Younes, Andrew D. Zelenetz, Ariela Noy
Journal: Blood
Blood (2024) 144 (Supplement 1): 6520.
https://doi.org/10.1182/blood-2024-210617
Published: 2024
Journal Articles

Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

Manik Uppal, Ashwath Gurumurthi, Paul A. Hamlin, Lorenzo Falchi, Steven Horwitz, Anita Kumar, Ariela Noy, Jennifer Kimberly Lue, Pallawi Torka, Maria E. Arcila, Ahmet Dogan, Brandon S. Imber, Joachim Yahalom, Olivier Elemento, Andrew D. Zelenetz, Gilles Salles, Erel Joffe
Journal: Blood
Blood (2024) 144 (Supplement 1): 4346.
https://doi.org/10.1182/blood-2024-198931
Published: 2024
Journal Articles

Multicenter Phase II Trial of Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in Treatment-Naïve Chronic Lymphocytic Leukemia: 5-Year Follow up, Retreatment Outcomes, and Impact of MRD Kinetics (ΔMRD400)

Jacob D. Soumerai, Ahmet Dogan, Venkatraman Seshan, Kelsey Leigh Flaherty, Natalie Slupe, Jason Carter, Ephraim Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Audrey Hamilton, Ariela Noy, Colette Owens, Maria Lia Palomba, Anita Kumar, Lindsey Roeker, Meghan C. Thompson, Ronald W. Takvorian, Zachary D. Epstein-Peterson, Mark Blaine Geyer, Gilles Salles, Robert Stuver, Philip Caron, Prioty Islam, Tamanna Haque, Paola Ghione, Raphael E. Steiner, Pallawi Torka, Kevin A. David, Jennifer Kimberly Lue, Paul A. Hamlin, Alison Moskowitz, Lorenzo Falchi, Julie Haydu, Patrick Connor Johnson, Joanna Mi, Jessica Pendleton, Alyssa Labarre, Rosalba Martignetti, Sean F. Plummer, Maria Chabowska, Walter Ramos Amador, Neena Mahajan, Morgan Choma, Clare Grieve, Rayna N. Garcia, Hailey E. Kelly, Ella Mallinger, James O'Grady, Bernadette Beatty, Michelle Adams, Athina Apazidis, Aileen Cleary Cohen, Mina Shahkarami, Allison P. Jacob, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1867.
https://doi.org/10.1182/blood-2024-205697
Published: 2024
Journal Articles

Single-Agent Mosunetuzumab Produces High Complete Response Rates in Patients with Newly Diagnosed Follicular Lymphoma: Primary Analysis of the Mithic-FL1 Trial

Lorenzo Falchi, Michelle Okwali, Alexandra Ferreira Lopes, Paul A. Hamlin, Jennifer Kimberly Lue, Paola Ghione, Colette Owens, Pallawi Torka, Anita Kumar, Raphael Steiner, Zachary D. Epstein-Peterson, Maria Lia Palomba, Robert Stuver, Ariela Noy, Anastasia Martinova, Lauren Wood, Clare Grieve, Walter Ramos Amador, Santosha A. Vardhana, Andrew D. Zelenetz, Lori A. Leslie, Joseph L. Roswarski, Kieron Dunleavy, Andre Goy, Gilles Salles
Journal: Blood
Blood (2024) 144 (Supplement 1): 340.
https://doi.org/10.1182/blood-2024-205046
Published: 2024
Journal Articles

Final Response and Survival Results from a Phase II Trial of Pembrolizumab and Entinostat in Relapsed/Refractory Hodgkin Lymphoma

Robert Stuver, Santosha A. Vardhana, Nivetha Ganesan, Alexander P. Boardman, Philip Caron, Tiffany Chang, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Francisco Hernandez-Ilizaliturri, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Reem Karmali, Jennifer Kimberly Lue, Anita Kumar, Efrat Luttwak, Neena Mahajan, Amira Marouf, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Heiko Schoder, David Sermer, Venkatraman Seshan, Raphael E. Steiner, Pallawi Torka, Andrew D. Zelenetz, Gottfried von Keudell, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3053.
https://doi.org/10.1182/blood-2024-210053
Published: 2024
Journal Articles

Tumor Determinants of Response to CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma

Zachary D. Epstein-Peterson, Christine E. Ryan, Sean M. Devlin, Noa Golan Accav, Abraham Avigdor, Magdalena Corona, Ivetta Danylesko, Jamie Dela Cruz, Andre Goy, Caron A. Jacobson, Ofrat Beyar Katz, Hazim Khatib, Anita Kumar, Lori A. Leslie, Alejandro Luna, Ronit Marcus, Reid W. Merryman, Miguel Angel Perales, Alfredo Rivas-Delgado, Gilles Salles, Michael Scordo, Inbal Sdayoor, Gunjan L. Shah, Noga Shem-Tov, Avichai Shimoni, Nataly Vahaba, Ronit Yerushalmi, Andrew D. Zelenetz, Maria Lia Palomba, Andrew Ip, Roni Shouval
Journal: Blood
Blood (2024) 144 (Supplement 1): 4393.
https://doi.org/10.1182/blood-2024-193091
Published: 2024
Journal Articles

Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Varun Iyengar, Jessica Chicola, Ashlee Joseph, Michelle Okwali, Regina Truong, Neil Bapodra, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Raphael E. Steiner, Robert Stuver, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin, Pallawi Torka
Journal: Blood
Blood (2024) 144 (Supplement 1): 2336.
https://doi.org/10.1182/blood-2024-202741
Published: 2024
Journal Articles

High Grade B-Cell Lymphoma with MYC/BCL6-Rearrangements (R) May Have Inferior Outcomes Compared to BCL2-R Disease

Sean E. Healton, Efrat Luttwak, Alfredo Rivas-Delgado, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Raphael E. Steiner, Robert Stuver, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Venkatraman Seshan, Pallavi Galera, Ahmet Dogan, Gilles Salles, Jennifer Lue
Journal: Blood
Blood (2024) 144 (Supplement 1): 1707.
https://doi.org/10.1182/blood-2024-194144
Published: 2024
Journal Articles

A Prospective Geriatric Assessment (GA) Study Predicting Toxicities in Older Adults (OA) with Non-Hodgkin Lymphoma (NHL): Timed up and Go Test (TUG) Time Emerges As a Functional Vital Sign

Pallawi Torka, Esther Drill, Nivetha Ganesan, Regina Truong, Annie Qiu, Walter Ramos Amador, Mayan Oliveros, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Raphael E. Steiner, Robert Stuver, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4474.
https://doi.org/10.1182/blood-2024-210711
Published: 2024
Journal Articles

Sequential R-CHOP/(R)-ICE and Dose-Adjusted EPOCH-R Are Both Appropriate Frontline Treatments for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma: Results of a Retrospective Analysis

Kurt S. Bantilan, Efrat Luttwak, Craig H. Moskowitz, Matthew Matasar, David J. Straus, Carol S. Portlock, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Steven Horwitz, Gilles Salles, Colette Owens, Pallawi Torka, Alexander P. Boardman, Kevin A. David, Zachary D. Epstein-Peterson, Anita Kumar, Philip Caron, Paola Ghione, Lorenzo Falchi, Jennifer K Lue, Raphael Steiner, Robert Stuver, Ahmet Dogan, Paul A. Hamlin, Andrew D. Zelenetz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4485.
https://doi.org/10.1182/blood-2024-205803
Published: 2024
Journal Articles

Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation

Clinical Trials & Observations
Anita Kumar, Jacob D. Soumerai, Jeremy S Abramson, Jeffrey A. Barnes, Philip C Caron, Shalini Chhabra, Maria Chabowska, Ahmet Dogan, Lorenzo Falchi, Clare Grieve, J. Erika Haydu, Patrick Connor Johnson, Ashlee Joseph, Hailey Kelly, Alyssa Labarre, Jennifer K Lue, Rosalba Martignetti, Joanna Mi, Alison J Moskowitz, Colette N Owens, Sean Plummer, Madeline Puccio, Gilles A. Salles, Venkatraman E Seshan, Elizabeth Simkins, Natalie Slupe, Honglei Zhang, Andrew D. Zelenetz
Journal: Blood
Blood blood.2024025563.
https://doi.org/10.1182/blood.2024025563
Published: 2024
Includes: Supplemental data
Journal Articles

Predicted Functional Consequences of TP53 Alterations and Prognosis in TP53 -Mutated Mantle Cell Lymphoma

Manik Uppal, Erel Joffe, Kurt S. Bantilan, Gilles Salles, Jacob Soumerai, Andrew D. Zelenetz, Anita Kumar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3006.
https://doi.org/10.1182/blood-2023-187599
Published: 2023
Journal Articles

A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on Tumor Lysis Syndrome (TLS) Risk and Safety of Outpatient Venetoclax Dose Escalation

Lindsey E. Roeker, Andrew D. Zelenetz, Jae H. Park, Andriy Derkach, Mark Blaine Geyer, Prioty Islam, Lorenzo Falchi, Maria Lia Palomba, Anita Kumar, Gilles Salles, Jennifer Kimberly Lue, Aaron D. Goldberg, Bita Fakhri, Catherine C. Coombs, Victoria Falco, Gail Panton, Dianna Tyznar, Dhara Soni, Lauren Nogan, Sonia Lebowitz, Katherine Blesie, Monica Shah, Sarah Court, Christopher E. Jensen, Anthony R. Mato, Meghan C. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4657.
https://doi.org/10.1182/blood-2023-181661
Published: 2023